Elsa Hansen
Assistant Research Professor - Read Lab
Research Summary
Evolution, transmission and management of drug-resistance. Improving treatment of infectious disease and cancer using mathematical models and optimal control theory.
Huck Affiliations
Publication Tags
Therapeutics Neoplasms Ecology Daptomycin Pharmaceutical Preparations Anti Bacterial Agents Parasites Cells Resistance Drug Resistance Bacteria Cancer Drugs Malaria Enterococcus Faecium Pathogens Vancomycin Antimicrobial Agent Population Blood Erythrocytes Mathematical Models Cell Tumor Drug TherapyMost Recent Publications
Identifying key questions in the ecology and evolution of cancer
Antoine Dujon, Athena Aktipis, Alix-Panabieres, Catherine, Sarah Amend, Amy Boddy, Joel Brown, Jean-Pascal Capp, James DeGregori, Paul Ewald, Robert Gatenby, Mathieu Giraudeau, Rodrigo Hamede, Elsa Hansen, Evolutionary Applications
Fighting microbial pathogens by integrating host ecosystem interactions and evolution
Alita Burgmeister, Elsa Hansen, Jessica Cunningham, E Rego, Paul Turner, Joshua Weitz, Michael Hochberg, BioEssays
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium
Clare L. Kinnear, Elsa Hansen, Valerie J. Morley, Kevin C. Tracy, Meghan Forstchen, Andrew F. Read, Robert J. Woods, 2020, PLoS Biology
An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen
Valerie J. Morley, Clare Kinnear, Derek G. Sim, Samantha N. Olson, Samantha Olsen, Lindsey Jackson, Elsa Hansen, Grace Usher, Scott A. Showalter, Manjunath Pai, Robert Woods, Andrew F. Read, 2020, eLife on p. 1-17
Modifying adaptive therapy to enhance competitive suppression
Elsa Hansen, Andrew F. Read, 2020, Cancers on p. 1-13
Cancer therapy: Attempt cure or manage drug resistance?
Elsa Hansen, Andrew F. Read, 2020, Evolutionary Applications on p. 1660-1672
Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations
Elsa Hansen, Jason Karslake, Robert J. Woods, Andrew F. Read, Kevin B. Wood, 2020, PLoS Biology
Accounting for red blood cell accessibility reveals distinct invasion strategies in Plasmodium falciparum strains
Francisco Y. Cai, Tiffany M. DeSimone, Elsa Hansen, Cameron V. Jennings, Amy K. Bei, Ambroise D. Ahouidi, Souleymane Mboup, Manoj T. Duraisingh, Caroline O. Buckee, 2020, PLoS Computational Biology
Fighting microbial pathogens by integrating host ecosystem interactions and evolution
Alita R. Burmeister, Elsa Hansen, Jessica J. Cunningham, E. Hesper Rego, Paul E. Turner, Joshua S. Weitz, Michael E. Hochberg, 2020, BioEssays
Identifying key questions in the ecology and evolution of cancer
Antoine M. Dujon, Athena Aktipis, Catherine Alix-Panabières, Sarah R. Amend, Amy M. Boddy, Joel S. Brown, Jean Pascal Capp, James DeGregori, Paul Ewald, Robert Gatenby, Marco Gerlinger, Mathieu Giraudeau, Rodrigo K. Hamede, Elsa Hansen, Irina Kareva, Carlo C. Maley, Andriy Marusyk, Nicholas McGranahan, Michael J. Metzger, Aurora M. Nedelcu, Robert Noble, Leonard Nunney, Kenneth J. Pienta, Kornelia Polyak, Pascal Pujol, Andrew F. Read, Benjamin Roche, Susanne Sebens, Eric Solary, Kateřina Staňková, Holly Swain Ewald, Frédéric Thomas, Beata Ujvari, 2020, Evolutionary Applications on p. 877-892
Most-Cited Papers
Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans
Caeul Lim, Elsa Hansen, Tiffany M. Desimone, Yovany Moreno, Klara Junker, Amy Bei, Carlo Brugnara, Caroline O. Buckee, Manoj T. Duraisingh, 2013, Nature Communications
Mobile phones and malaria: Modeling human and parasite travel
Caroline O. Buckee, Amy Wesolowski, Nathan N. Eagle, Elsa Hansen, Robert W. Snow, 2013, Travel Medicine and Infectious Disease on p. 15-22
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Elsa Hansen, Robert J. Woods, Andrew F. Read, 2017, PLoS Biology
Identifying key questions in the ecology and evolution of cancer
Antoine M. Dujon, Athena Aktipis, Catherine Alix-Panabières, Sarah R. Amend, Amy M. Boddy, Joel S. Brown, Jean Pascal Capp, James DeGregori, Paul Ewald, Robert Gatenby, Marco Gerlinger, Mathieu Giraudeau, Rodrigo K. Hamede, Elsa Hansen, Irina Kareva, Carlo C. Maley, Andriy Marusyk, Nicholas McGranahan, Michael J. Metzger, Aurora M. Nedelcu, Robert Noble, Leonard Nunney, Kenneth J. Pienta, Kornelia Polyak, Pascal Pujol, Andrew F. Read, Benjamin Roche, Susanne Sebens, Eric Solary, Kateřina Staňková, Holly Swain Ewald, Frédéric Thomas, Beata Ujvari, 2020, Evolutionary Applications on p. 877-892
Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations
Elsa Hansen, Jason Karslake, Robert J. Woods, Andrew F. Read, Kevin B. Wood, 2020, PLoS Biology
Modifying adaptive therapy to enhance competitive suppression
Elsa Hansen, Andrew F. Read, 2020, Cancers on p. 1-13
Cancer therapy: Attempt cure or manage drug resistance?
Elsa Hansen, Andrew F. Read, 2020, Evolutionary Applications on p. 1660-1672
Modeling the human infectious reservoir for malaria control: Does heterogeneity matter?
Elsa Hansen, Caroline O. Buckee, 2013, Trends in Parasitology on p. 270-275
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium
Clare L. Kinnear, Elsa Hansen, Valerie J. Morley, Kevin C. Tracy, Meghan Forstchen, Andrew F. Read, Robert J. Woods, 2020, PLoS Biology
On the accuracy of drug-resistant cell population estimation from total cancer size measurements
Mahsa Doosthosseini, Elsa Hansen, Hosam K. Fathy, 2019, on p. 343-350